Filana Therapeutics Inc (FLNA)

Jun 15, 2026

FLNA Q3 2025 Earnings: Narrower-Than-Expected Loss Highlights Operational DisciplineEarnings Trend Analysis - newsline.com

Jun 15, 2026

Jun 15, 2026

Filana Therapeutics, Inc. 8-K Filing Details: Amended 2018 Omnibus Incentive Plan and Company Information (June 2026) – Minichart - Minichart

Jun 15, 2026

Jun 15, 2026

Filana Therapeutics Shareholders Back Board, Compensation Plans - TipRanks

Jun 15, 2026

Jun 15, 2026

Filana Therapeutics (FLNA) investors back directors, plan changes and auditor - Stock Titan

Jun 15, 2026

Jun 13, 2026

Filana Therapeutics (FLNA) Slips 4.6% as Biotech Sector Headwinds Test SupportConversion Trade - newsline.com

Jun 13, 2026

Jun 12, 2026

FLNA Should I Buy - Intellectia AI

Jun 12, 2026

Jun 10, 2026

FLNA Price Today: Filana Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Jun 10, 2026

Jun 08, 2026

Filana Therapeutics (FLNA) Surges Over 8%—Testing Key Resistance at $1.50Beta Neutral Pair - newsline.com

Jun 08, 2026

Jun 04, 2026

Filana Therapeutics (FLNA) Edges Higher as Stock Tests Key Resistance LevelTrend Following Picks - newsline.com

Jun 04, 2026

Jun 03, 2026

Filana Therapeutics (FLNA) Slips 4.5% as Stock Approaches Key Support LevelIV Rank - newsline.com

Jun 03, 2026

May 31, 2026

MSN Money - MSN

May 31, 2026

May 29, 2026

Data I/O And 2 Other Promising Penny Stocks To Watch - simplywall.st

May 29, 2026

May 28, 2026

FLNA Q3 2025 Earnings: Narrower-Than-Expected Loss Drives Stock RallyEarnings Surprise Stocks - The Legal Advocate

May 28, 2026

May 28, 2026

FLNA Q3 2025 Earnings: Narrower-Than-Expected Loss Propels Shares HigherSurprise Factor Analysis - The Legal Advocate

May 28, 2026

May 27, 2026

Filana Therapeutics (FLNA) Gains 6.38% as Biotech Momentum BuildsPCR Spike - newsline.com

May 27, 2026

May 26, 2026

FLNA Reinstated by Maxim Group -- Price Target Announced at $5.0 - GuruFocus

May 26, 2026

May 26, 2026

FLNA Reinstated by Maxim Group -- Price Target Announced at $5.00 - GuruFocus

May 26, 2026

May 23, 2026

Filana Therapeutics (FLNA) Posts Modest Gains Amid Broader Biotech ResilienceExpert Breakout Alerts - Newser

May 23, 2026

May 21, 2026

Filana Therapeutics (FLNA) Stock: Up +0.80%, Key Resistance at $1.32 2026-05-21IPO Entry Watch - The Legal Advocate

May 21, 2026

May 07, 2026

Filana Therapeutics 1Q Loss/Shr 21c >FLNA - Moomoo

May 07, 2026

May 07, 2026

FLNA SEC FilingsFilana Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan

May 07, 2026

May 07, 2026

Filana Therapeutics (NASDAQ: FLNA) trims Q1 2026 loss, pivots simufilam to TSC epilepsy - Stock Titan

May 07, 2026

May 07, 2026

Filana Therapeutics Releases Q1 2026 Financial Results and Business Update on May 7, 2026 - geneonline.com

May 07, 2026

May 07, 2026

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update - The Manila Times

May 07, 2026

May 07, 2026

Cost cuts shrink Filana Therapeutics (NASDAQ: FLNA) Q1 2026 net loss - Stock Titan

May 07, 2026

May 07, 2026

Biotech with $86.6M cash says FDA hold keeps epilepsy trial on hold - Stock Titan

May 07, 2026

May 05, 2026

Cassava Sciences | 8-K: Current report - Moomoo

May 05, 2026

May 05, 2026

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII - markets.businessinsider.com

May 05, 2026

May 05, 2026

At a Madrid epilepsy meeting, Filana detailed why it’s testing simufilam - Stock Titan

May 05, 2026

May 05, 2026

MSN - MSN

May 05, 2026